Skip to content

RTW INVESTMENTS, LP

Follow

13F filer, CIK 1493215, NEW YORK, NY

RTW INVESTMENTS, LP reported $9,921,520,189 across 83 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 43.42% of the portfolio.

Accepted , ingested 13F-HR 0001493215-26-000214

Period
2026-09-30
Reported value
$9.92B
Holdings
83
Top 10 weight
43.42%
New
12
Sold out
13

Part of the filer group RTW INVESTMENTS, LP

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IRTCadded+936,282$106M
VRDNnew+4,910,126$101M
ZLABadded+3,776,941$99.5M
ERASadded+4,500,000$66M
KRSAnew+877,020$28.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MDGLreduced-1,680,870-$847M
PTCTreduced-6,130,596-$397M
INSMreduced-1,746,335-$199M
NTRAreduced-400,000-$165M
ALKSexited-1,672,356-$87.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001493215-26-000214, largest first. % of portfolio is the value over $9,921,520,189, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,498,545 shares; 2025Q1: 5,719,415 shares; 2025Q2: 5,756,277 shares; 2025Q3: 5,756,277 shares; 2025Q4: 5,059,053 shares; 2026Q1: 5,059,053 shares; 2026Q2: 5,061,175 shares; 2026Q3: 5,061,175 shares 5,061,175$713M7.19%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 673,497 shares; 2025Q1: 673,497 shares; 2025Q2: 673,497 shares; 2025Q3: 673,497 shares; 2025Q4: 673,497 shares; 2026Q1: 709,446 shares; 2026Q2: 709,446 shares; 2026Q3: 711,584 shares 711,584$682M6.88%+2,138Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,701,216 shares; 2025Q1: 1,701,216 shares; 2025Q2: 1,701,216 shares; 2025Q3: 1,701,216 shares; 2025Q4: 2,012,127 shares; 2026Q1: 6,984,808 shares; 2026Q2: 8,514,590 shares; 2026Q3: 8,514,590 shares 8,514,590$604M6.08%0Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,181,990 shares; 2026Q1: 1,668,500 shares; 2026Q2: 2,182,631 shares; 2026Q3: 3,118,913 shares 3,118,913$354M3.57%+936,282Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,014,558 shares; 2025Q1: 3,014,558 shares; 2025Q2: 3,084,558 shares; 2025Q3: 3,084,558 shares; 2025Q4: 4,842,879 shares; 2026Q1: 4,842,880 shares; 2026Q2: 4,842,880 shares; 2026Q3: 3,096,545 shares 3,096,545$353M3.56%-1,746,335Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,491,228 shares; 2026Q1: 13,300,620 shares; 2026Q2: 13,900,620 shares; 2026Q3: 14,048,477 shares 14,048,477$351M3.53%+147,857Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,651 shares; 2026Q1: 16,157,175 shares; 2026Q2: 17,946,754 shares; 2026Q3: 22,446,754 shares 22,446,754$329M3.32%+4,500,000Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,621,996 shares; 2025Q1: 3,621,996 shares; 2025Q2: 3,621,996 shares; 2025Q3: 3,621,996 shares; 2025Q4: 4,171,996 shares; 2026Q1: 4,171,996 shares; 2026Q2: 4,251,996 shares; 2026Q3: 3,691,791 shares 3,691,791$329M3.31%-560,205Timeline
RDNTRADNET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,978,582 shares; 2025Q1: 2,317,582 shares; 2025Q2: 2,690,344 shares; 2025Q3: 2,815,544 shares; 2025Q4: 3,938,500 shares; 2026Q1: 4,285,000 shares; 2026Q2: 4,846,958 shares; 2026Q3: 4,630,697 shares 4,630,697$319M3.22%-216,261Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,236,549 shares; 2025Q1: 3,316,032 shares; 2025Q2: 3,111,680 shares; 2025Q3: 3,177,436 shares; 2025Q4: 3,335,320 shares; 2026Q1: 3,346,025 shares; 2026Q2: 3,357,059 shares; 2026Q3: 3,484,066 shares 3,484,066$274M2.76%+127,007Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,509,119 shares; 2025Q1: 3,136,680 shares; 2025Q2: 5,536,876 shares; 2025Q3: 2,291,372 shares; 2025Q4: 6,959,032 shares; 2026Q1: 6,574,032 shares; 2026Q2: 6,574,032 shares; 2026Q3: 10,350,973 shares 10,350,973$273M2.75%+3,776,941Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,064,000 shares; 2026Q1: 1,206,000 shares; 2026Q2: 1,240,637 shares; 2026Q3: 1,385,398 shares 1,385,398$266M2.68%+144,761Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 856,501 shares; 2025Q3: 1,481,033 shares; 2025Q4: 1,481,033 shares; 2026Q1: 1,481,033 shares; 2026Q2: 1,481,033 shares; 2026Q3: 1,481,033 shares 1,481,033$264M2.66%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 550,160 shares; 2026Q1: 3,039,621 shares; 2026Q2: 3,304,903 shares; 2026Q3: 3,304,903 shares 3,304,903$263M2.65%0Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,945,649 shares; 2025Q1: 1,945,649 shares; 2025Q2: 1,945,649 shares; 2025Q3: 1,945,649 shares; 2025Q4: 2,058,148 shares; 2026Q1: 2,058,148 shares; 2026Q2: 3,139,030 shares; 2026Q3: 3,139,030 shares 3,139,030$261M2.64%0Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,593,323 shares; 2025Q1: 2,593,546 shares; 2025Q2: 2,593,645 shares; 2025Q3: 2,000,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,250,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 600,000 shares 600,000$248M2.5%-400,000Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,721,158 shares; 2025Q1: 2,721,158 shares; 2025Q2: 2,721,158 shares; 2025Q3: 2,721,158 shares; 2025Q4: 2,721,158 shares; 2026Q1: 2,721,158 shares; 2026Q2: 2,862,003 shares; 2026Q3: 2,862,003 shares 2,862,003$189M1.9%0Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,834,794 shares; 2025Q1: 3,834,794 shares; 2025Q2: 4,543,895 shares; 2025Q3: 4,543,895 shares; 2025Q4: 4,543,895 shares; 2026Q1: 4,543,895 shares; 2026Q2: 4,543,895 shares; 2026Q3: 4,543,895 shares 4,543,895$185M1.86%0Timeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,569,687 shares; 2025Q1: 2,583,887 shares; 2025Q2: 2,584,131 shares; 2025Q3: 2,588,831 shares; 2025Q4: 2,588,831 shares; 2026Q1: 2,655,695 shares; 2026Q2: 2,655,695 shares; 2026Q3: 2,665,695 shares 2,665,695$171M1.72%+10,000Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,402,883 shares; 2025Q1: 2,402,883 shares; 2025Q2: 2,402,883 shares; 2025Q3: 6,221,054 shares; 2025Q4: 6,777,461 shares; 2026Q1: 6,777,461 shares; 2026Q2: 6,777,461 shares; 2026Q3: 6,827,461 shares 6,827,461$170M1.72%+50,000Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,993,687 shares; 2025Q1: 1,993,687 shares; 2025Q2: 1,993,687 shares; 2025Q3: 1,993,687 shares; 2025Q4: 1,993,687 shares; 2026Q1: 1,993,687 shares; 2026Q2: 1,993,687 shares; 2026Q3: 312,817 shares 312,817$158M1.59%-1,680,870Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,869,798 shares; 2025Q1: 4,869,798 shares; 2025Q2: 4,869,798 shares; 2025Q3: 4,869,798 shares; 2025Q4: 4,869,798 shares; 2026Q1: 4,869,798 shares; 2026Q2: 4,869,798 shares; 2026Q3: 4,869,798 shares 4,869,798$148M1.49%0Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,123,525 shares; 2025Q1: 5,123,525 shares; 2025Q2: 5,123,525 shares; 2025Q3: 5,123,525 shares; 2025Q4: 5,546,856 shares; 2026Q1: 5,623,525 shares; 2026Q2: 5,623,525 shares; 2026Q3: 5,623,525 shares 5,623,525$146M1.47%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,705,501 shares; 2025Q1: 8,540,117 shares; 2025Q2: 8,995,547 shares; 2025Q3: 7,144,524 shares; 2025Q4: 7,144,524 shares; 2026Q1: 7,144,524 shares; 2026Q2: 7,144,524 shares; 2026Q3: 7,144,524 shares 7,144,524$144M1.45%0Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,487,933 shares; 2026Q1: 1,487,934 shares; 2026Q2: 1,487,934 shares; 2026Q3: 1,487,934 shares 1,487,934$141M1.42%0Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,327,129 shares; 2025Q1: 5,499,769 shares; 2025Q2: 5,540,457 shares; 2025Q3: 5,569,564 shares; 2025Q4: 5,933,815 shares; 2026Q1: 5,933,815 shares; 2026Q2: 5,933,815 shares; 2026Q3: 5,933,815 shares 5,933,815$139M1.4%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,098,987 shares; 2025Q1: 5,538,168 shares; 2025Q2: 8,221,929 shares; 2025Q3: 8,707,390 shares; 2025Q4: 8,757,390 shares; 2026Q1: 10,632,390 shares; 2026Q2: 10,700,974 shares; 2026Q3: 10,948,591 shares 10,948,591$136M1.37%+247,617Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,062,072 shares; 2025Q3: 1,062,072 shares; 2025Q4: 1,062,072 shares; 2026Q1: 1,062,072 shares; 2026Q2: 1,267,925 shares; 2026Q3: 942,684 shares 942,684$134M1.35%-325,241Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,968,002 shares; 2025Q1: 1,707,402 shares; 2025Q2: 1,707,402 shares; 2025Q3: 3,258,266 shares; 2025Q4: 3,000,139 shares; 2026Q1: 3,648,795 shares; 2026Q2: 7,796,895 shares; 2026Q3: 8,529,394 shares 8,529,394$128M1.29%+732,499Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,776,820 shares; 2026Q3: 10,776,820 shares 10,776,820$123M1.24%0Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 312,500 shares; 2025Q4: 715,332 shares; 2026Q1: 715,332 shares; 2026Q2: 715,332 shares; 2026Q3: 715,332 shares 715,332$121M1.22%0Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,540,540 shares; 2025Q1: 6,909,510 shares; 2025Q2: 6,970,152 shares; 2025Q3: 8,815,617 shares; 2025Q4: 11,433,354 shares; 2026Q1: 12,869,340 shares; 2026Q2: 12,946,176 shares; 2026Q3: 13,521,551 shares 13,521,551$119M1.2%+575,375Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,065,010 shares; 2025Q1: 2,065,010 shares; 2025Q2: 2,065,010 shares; 2025Q3: 6,395,732 shares; 2025Q4: 7,140,352 shares; 2026Q1: 7,356,916 shares; 2026Q2: 7,411,581 shares; 2026Q3: 8,491,525 shares 8,491,525$112M1.13%+1,079,944Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 530,614 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,177,850 shares; 2026Q1: 3,177,849 shares; 2026Q2: 3,177,849 shares; 2026Q3: 3,177,849 shares 3,177,849$107M1.08%0Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,393,127 shares; 2025Q1: 7,483,127 shares; 2025Q2: 7,746,415 shares; 2025Q3: 7,746,415 shares; 2025Q4: 7,746,415 shares; 2026Q1: 7,746,415 shares; 2026Q2: 7,746,415 shares; 2026Q3: 1,615,819 shares 1,615,819$105M1.06%-6,130,596Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,910,126 shares 4,910,126$101M1.02%newTimeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,115,237 shares; 2026Q1: 2,758,335 shares; 2026Q2: 2,778,335 shares; 2026Q3: 2,778,335 shares 2,778,335$98.7M0.99%0Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 903,625 shares; 2025Q1: 4,265,428 shares; 2025Q2: 5,158,231 shares; 2025Q3: 4,424,968 shares; 2025Q4: 3,711,462 shares; 2026Q1: 2,586,356 shares; 2026Q2: 3,941,572 shares; 2026Q3: 3,941,572 shares 3,941,572$95.2M0.96%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,467,486 shares; 2025Q4: 7,592,241 shares; 2026Q1: 5,458,675 shares; 2026Q2: 2,309,021 shares; 2026Q3: 2,309,021 shares 2,309,021$73.9M0.75%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 125,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: not reported; 2026Q2: 1,607,507 shares; 2026Q3: 2,282,138 shares 2,282,138$71.4M0.72%+674,631Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,011,576 shares; 2026Q3: 1,659,376 shares 1,659,376$69.6M0.7%+647,800Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,672,630 shares; 2025Q1: 18,787,866 shares; 2025Q2: 25,021,584 shares; 2025Q3: 24,354,291 shares; 2025Q4: 16,398,297 shares; 2026Q1: 13,680,248 shares; 2026Q2: 13,560,258 shares; 2026Q3: 13,560,258 shares 13,560,258$66M0.67%0Timeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,206,162 shares; 2025Q1: 8,206,162 shares; 2025Q2: 8,306,062 shares; 2025Q3: 8,306,063 shares; 2025Q4: 8,306,063 shares; 2026Q1: 8,306,063 shares; 2026Q2: 9,556,063 shares; 2026Q3: 9,556,063 shares 9,556,063$59.4M0.6%02026-11-09, 13D/A: 13,142,394 shares, 16.2% of the class, 13D/A filed 2026-11-12 Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 4,245,476 shares; 2025Q2: 4,251,616 shares; 2025Q3: 5,426,306 shares; 2025Q4: 6,576,306 shares; 2026Q1: 6,576,306 shares; 2026Q2: 6,635,793 shares; 2026Q3: 6,718,081 shares 6,718,081$54.1M0.55%+82,288Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 230,000 shares; 2026Q3: 230,000 shares 230,000$51M0.51%0Timeline
HNGEHINGE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 353,500 shares; 2026Q1: 1,930,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$48.6M0.49%0Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 17,687,772 shares; 2025Q1: 17,687,772 shares; 2025Q2: 17,687,772 shares; 2025Q3: 17,687,772 shares; 2025Q4: 17,687,772 shares; 2026Q1: 17,687,772 shares; 2026Q2: 17,687,772 shares; 2026Q3: 17,687,772 shares 17,687,772$46.5M0.47%0Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,892,926 shares; 2026Q3: 5,905,426 shares 5,905,426$42.7M0.43%+2,012,500Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,350,256 shares; 2025Q1: 1,348,656 shares; 2025Q2: 1,362,456 shares; 2025Q3: 1,362,456 shares; 2025Q4: 1,362,456 shares; 2026Q1: 1,362,456 shares; 2026Q2: 1,362,456 shares; 2026Q3: 1,512,456 shares 1,512,456$42.1M0.42%+150,000Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,705,960 shares; 2025Q1: 1,705,960 shares; 2025Q2: 1,705,960 shares; 2025Q3: 1,705,960 shares; 2025Q4: 1,705,960 shares; 2026Q1: 1,705,960 shares; 2026Q2: 2,364,347 shares; 2026Q3: 2,364,347 shares 2,364,347$36.3M0.37%0Timeline
AQSTAQUESTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,250,000 shares; 2025Q4: 6,250,000 shares; 2026Q1: 7,426,471 shares; 2026Q2: 7,426,471 shares; 2026Q3: 7,426,471 shares 7,426,471$34.4M0.35%0Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,422,018 shares; 2026Q2: 6,422,018 shares; 2026Q3: 3,211,008 shares 3,211,008$33.5M0.34%-3,211,010Timeline
AKTSAKTIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,592,043 shares; 2026Q2: 1,592,043 shares; 2026Q3: 1,592,043 shares 1,592,043$31M0.31%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,952,380 shares; 2026Q1: 5,952,380 shares; 2026Q2: 5,952,380 shares; 2026Q3: 5,952,380 shares 5,952,380$30.7M0.31%0Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 877,020 shares 877,020$28.1M0.28%newTimeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 240,000 shares; 2026Q1: 240,000 shares; 2026Q2: 240,000 shares; 2026Q3: 240,000 shares 240,000$26.8M0.27%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 666,667 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 248,063 shares; 2026Q2: 248,063 shares; 2026Q3: 248,063 shares 248,063$21.8M0.22%0Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,299,870 shares; 2025Q2: 3,299,191 shares; 2025Q3: 3,299,191 shares; 2025Q4: 2,500,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 998,855 shares 998,855$19M0.19%-501,145Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,125,000 shares; 2025Q4: 3,125,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 2,565,999 shares; 2026Q3: 5,820,891 shares 5,820,891$18.6M0.19%+3,254,892Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 6,506,229 shares 6,506,229$15.2M0.15%newTimeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,695,652 shares; 2026Q2: 8,695,652 shares; 2026Q3: 8,695,652 shares 8,695,652$14.9M0.15%0Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 438,659 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 570,394 shares; 2026Q1: 570,394 shares; 2026Q2: 570,394 shares; 2026Q3: 570,394 shares 570,394$13.9M0.14%0Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 393,560 shares 393,560$12.7M0.13%newTimeline
HTFLHEARTFLOW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 495,000 shares; 2025Q4: 495,000 shares; 2026Q1: 495,000 shares; 2026Q2: 295,000 shares; 2026Q3: 250,000 shares 250,000$12.4M0.13%-45,000Timeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 742,500 shares 742,500$11.7M0.12%newTimeline
LTGOLATIGO BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000$11.7M0.12%newTimeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 700,000 shares 700,000$7.65M0.08%newTimeline
OCGNOCUGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,666,666 shares; 2026Q2: 6,666,666 shares; 2026Q3: 6,666,666 shares 6,666,666$6.87M0.07%0Timeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,506,102 shares; 2025Q1: 2,506,102 shares; 2025Q2: 2,506,102 shares; 2025Q3: 2,506,102 shares; 2025Q4: 2,506,102 shares; 2026Q1: 6,331,001 shares; 2026Q2: 7,833,336 shares; 2026Q3: 7,833,336 shares 7,833,336$6.78M0.07%0Timeline
ADRXADARX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$5.98M0.06%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 372,856 shares; 2026Q1: 372,856 shares; 2026Q2: 372,856 shares; 2026Q3: 372,856 shares 372,856$5.44M0.05%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,250,000 shares; 2026Q3: 3,250,000 shares 3,250,000$5.2M0.05%0Timeline
LMRILUMEXA IMAGING HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 650,000 shares; 2026Q1: 650,000 shares; 2026Q2: 650,000 shares; 2026Q3: 500,000 shares 500,000$5.12M0.05%-150,000Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,218,641 shares; 2025Q1: 1,690,567 shares; 2025Q2: 1,690,567 shares; 2025Q3: 2,890,567 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$4.83M0.05%newTimeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 555,555 shares 555,555$4.18M0.04%newTimeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,300,000 shares; 2026Q1: 1,300,000 shares; 2026Q2: 1,300,000 shares; 2026Q3: 1,300,000 shares 1,300,000$3.76M0.04%0Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,000 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 26,400 shares; 2026Q3: 26,400 shares 26,400$2.61M0.03%0Timeline
MDLNMEDLINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares; 2026Q1: 70,000 shares; 2026Q2: 70,000 shares; 2026Q3: 70,000 shares 70,000$2.43M0.02%0Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000$2.37M0.02%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares; 2026Q2: 30,000 shares; 2026Q3: 30,000 shares 30,000$1.96M0.02%0Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,283,671 shares; 2026Q1: 1,502,235 shares; 2026Q2: 1,502,235 shares; 2026Q3: 208,071 shares 208,071$1.72M0.02%-1,294,164Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 67,706 shares 67,706$930K0.01%newTimeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 239,149 shares 239,149$808K0.01%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ALKSALKERMES PLC1,672,356$87.6Mshares
DFTXDEFINIUM THERAPEUTICS INC400,000$18.8Mshares
IDYAIDEAYA BIOSCIENCES INC370,370$13.8Mshares
ATAIATAIBECKLEY INC2,000,000$10.5Mshares
TENXTENAX THERAPEUTICS INC696,570$10.1Mshares
FRNMPERCEPTIVE CAP SOLUTIONS COR742,500$8.08Mshares
WVEWAVE LIFE SCIENCES LTD1,350,000$7.84Mshares
FDMT4D MOLECULAR THERAPEUTICS IN475,737$6.33Mshares
MAZEMAZE THERAPEUTICS INC212,000$6.33Mshares
AVTXAVALO THERAPEUTICS INC175,000$3.23Mshares
IMAIMAGENEBIO INC334,445$1.97Mshares
XGNEXAGEN INC195,000$907Kshares
RCKTWROCKET PHARMACEUTICALS INC350,000$1.19Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001493215-26-000214 base2026-11-16